OTCMKTS:RHHVF Roche (RHHVF) Stock Price, News & Analysis $340.00 -5.04 (-1.46%) As of 03/26/2025 03:43 PM Eastern Add Compare Share Share Stock Analysis Stock AnalysisChartDividendHeadlinesShort InterestBuy This Stock About Roche Stock (OTCMKTS:RHHVF) 30 days 90 days 365 days Advanced Chart View Price History Chart DataSkip Price History Chart Get Roche alerts:Sign Up Key Stats Today's Range$336.43▼$346.6750-Day Range$288.70▼$351.5052-Week Range$233.12▼$354.19Volume956 shsAverage Volume4,585 shsMarket CapitalizationN/AP/E Ratio31.45Dividend Yield2.29%Price TargetN/AConsensus RatingN/A Company OverviewRoche Holding AG engages in the pharmaceuticals and diagnostics businesses in Europe, North America, Latin America, Asia, Africa, Australia, and Oceania. The company offers pharmaceutical products in the therapeutic areas of anemia, blood and solid tumors, dermatology, hemophilia, inflammatory and autoimmune, neurological disorders, ophthalmology, respiratory disorders, and transplantation. It is also developing products for various therapeutic areas. In addition, it offers in vitro tests for the diagnosis of various diseases, such as cancer, diabetes, Covid-19, hepatitis, human papillomavirus, and other diseases; diagnostic instruments; and digital health solutions. Roche Holding AG was founded in 1896 and is based in Basel, Switzerland.Read More… Remove Ads Roche Stock Analysis - MarketRank™See Top-Rated MarketRank™ Stocks6th Percentile Overall ScoreRHHVF MarketRank™: Roche scored higher than 6% of companies evaluated by MarketBeat. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation. Analyst's OpinionN/AAnalyst RatingN/A Consensus RatingThere is not enough analysis data for Roche. Earnings and Valuation0.0 / 5Proj. Earnings GrowthN/A Price to Earnings Ratio vs. the MarketThe P/E ratio of Roche is 31.45, which means that it is trading at a more expensive P/E ratio than the market average P/E ratio of about 22.79.Price to Earnings Ratio vs. SectorThe P/E ratio of Roche is 31.45, which means that it is trading at a more expensive P/E ratio than the Medical sector average P/E ratio of about 24.53. Short Interest1.0 / 5Short Interest LevelBearish Percentage of Shares ShortedShort Interest Ratio / Days to CoverRoche has a short interest ratio ("days to cover") of 164.9, which indicates bearish sentiment.Change versus previous monthShort interest in Roche has recently decreased by 1.91%, indicating that investor sentiment is improving. Dividend1.7 / 5Dividend StrengthWeak Dividend YieldRoche pays a meaningful dividend of 3.21%, higher than the bottom 25% of all stocks that pay dividends.Dividend GrowthRoche does not have a long track record of dividend growth.Dividend CoverageThe dividend payout ratio of Roche is 72.16%. This payout ratio is at a healthy, sustainable level, below 75%.Read more about Roche's dividend. Sustainability and ESGN/AEnvironmental ScoreN/A Percentage of Shares ShortedShort Interest Ratio / Days to CoverRoche has a short interest ratio ("days to cover") of 164.9, which indicates bearish sentiment.Change versus previous monthShort interest in Roche has recently decreased by 1.91%, indicating that investor sentiment is improving. News and Social Media2.8 / 5News SentimentN/A News SentimentRoche has a news sentiment score of 1.00. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.82 average news sentiment score of Medical companies.News Coverage This WeekMarketBeat has tracked 1 news article for Roche this week, compared to 1 article on an average week.MarketBeat Follows1 people have added Roche to their MarketBeat watchlist in the last 30 days. Company Ownership0.0 / 5Insider TradingN/A Insider Buying vs. Insider SellingIn the past three months, Roche insiders have not sold or bought any company stock.Percentage Held by InstitutionsOnly 29.01% of the stock of Roche is held by institutions.Read more about Roche's insider trading history. Receive RHHVF Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Roche and its competitors with MarketBeat's FREE daily newsletter. Email Address RHHVF Stock News HeadlinesRoche Holding AG (RHHVF) Receives a Buy from Kepler CapitalMarch 19, 2025 | markets.businessinsider.comBernstein Sticks to Its Buy Rating for Roche Holding AG (RHHVF)March 12, 2025 | markets.businessinsider.comWhy Buffett and 100 members of Congress are Piling into this One InvestmentWhile everyone's distracted by the recent stock market rally and Trump's tariffs... There's a much bigger story that's flying under the radar for now: Why are Warren Buffett, Ken Griffin, Roman Abramovich, the Koch Brothers, Carlos Slim and at least 100 members of Congress all going against "conventional wisdom?" And why are they all piling into ONE overlooked corner of the stock market? It's not crypto... gold... or options strategies.March 27, 2025 | Behind the Markets (Ad)Analysts Offer Insights on Healthcare Companies: Knight Therapeutics (OtherKHTRF) and Roche Holding AG (OtherRHHVF)March 12, 2025 | markets.businessinsider.comAnalysts Offer Insights on Healthcare Companies: Protagonist Therapeutics (PTGX) and Roche Holding AG (OtherRHHVF)March 10, 2025 | markets.businessinsider.comBerenberg Bank Sticks to Their Hold Rating for Roche Holding AG (RHHVF)February 27, 2025 | markets.businessinsider.comAnalysts Offer Insights on Healthcare Companies: Roche Holding AG (OtherRHHVF) and Repligen (RGEN)February 24, 2025 | markets.businessinsider.comRoche Holding AG (RHHVF) Gets a Buy from UBSFebruary 21, 2025 | markets.businessinsider.comSee More Headlines RHHVF Stock Analysis - Frequently Asked Questions How have RHHVF shares performed this year? Roche's stock was trading at $280.00 at the beginning of 2025. Since then, RHHVF stock has increased by 21.4% and is now trading at $340.00. View the best growth stocks for 2025 here. How do I buy shares of Roche? Shares of RHHVF stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Company Calendar Today3/27/2025Ex-Dividend for 3/31 Dividend3/27/2025Record date for 3/31 Dividend3/28/2025Dividend Payable3/31/2025Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeOTCMKTS SectorMedical Industry Drug Manufacturers - General Sub-IndustryPersonal Services Current SymbolOTCMKTS:RHHVF CIKN/A Webwww.roche.com Phone(161) 688-1111FaxN/AEmployees103,605Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)N/A Trailing P/E Ratio31.45 Forward P/E RatioN/A P/E GrowthN/ANet IncomeN/A Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on AssetsN/A Debt Debt-to-Equity RatioN/A Current RatioN/A Quick RatioN/A Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book ValueN/A Price / BookN/AMiscellaneous Outstanding SharesN/AFree FloatN/AMarket CapN/A OptionableNot Optionable BetaN/A 7 Energy Stocks to Buy and Hold ForeverWith the proliferation of data centers and electric vehicles, the electric grid will only get more strained. Download this report to learn how energy stocks can play a role in your portfolio as the global demand for energy continues to grow.Get This Free Report This page (OTCMKTS:RHHVF) was last updated on 3/27/2025 by MarketBeat.com Staff From Our PartnersA market crash is coming—here’s whenThe stock market cycle I've used to identify the most likely day of the next market crash is the exact same in...Chaikin Analytics | SponsoredYour Wealth is Under AttackPlease don't wait—this is your moment to take action. Download your Wealth Protection Guide now, claim your fr...American Alternative | SponsoredA brutally honest economic warning for 2025 (see proof)New York Times best-selling financial author and world-renowned economist Addison Wiggin (a man who’s worked s...Banyan Hill Publishing | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredHas Trump finally met his match?Dylan Jovine predicted the 2008 crash over a year before it happened. Folks who listened to him had the chance...Behind the Markets | SponsoredEx CIA predicts 40% “double crash” – April 11The scientists here don’t study deadly viruses… directed energy weapons… or even weather control technology… ...Paradigm Press | Sponsored“Amazon Coin” set to outperform BitcoinChris Rowe – the man who recommended Amazon in 1998… Bitcoin and Ethereum in 2017… And has spotted 44 diffe...True Market Insiders | SponsoredUrgent Bitcoin alert for RIGHT NOWFormer billion-dollar hedge fund manager Larry Benedict has released the most incredible presentation of his 4...Brownstone Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Roche Holding AG Please log in to your account or sign up in order to add this asset to your watchlist. Share Roche With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.